Abdallah Gaballa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Abdallah Gaballa has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Carsten Patrick Ade
Department of Biochemistry and Molecular Biology, University of Wuerzburg, Wuerzburg, Germany
21 shared publications Anneli Gebhardt-Wolf
Department of Biochemistry and Molecular Biologyy, Theodor Boveri Institute, Biocenter, Julius Maximilian University Würzburg, Am Hubland, Würzburg, Germany
20 shared publications- Apoorva Baluapuri
Department of Biochemistry and Molecular Biology, University of Würzburg, Würzburg, Germany
20 shared publications - Bastian Krenz
Chair of Biochemistry and Molecular Biology, Theodor Boveri Institute, University of Würzburg, Würzburg, Germany
20 shared publications - Elmar Wolf
Institute of Biochemistry, University of Kiel, Kiel, Germany
20 shared publications - Georg Gasteiger
Würzburg Institute of Systems Immunology, Max Planck Research Group at the Julius-Maximilians-Universität Würzburg, Würzburg, Germany
20 shared publications
Latest Publications
- Open Access
MYC: The Guardian of Its Own Chaos
MYC proteins are potent oncoproteins that drive tumorigenesis in a wide range of cancers, making it critical to understand their oncogenic functions and underlying mechanisms. Although MYC overexpression induces transcriptional and replication‐associated stress, recent studies have paradoxically identified MYC as a key resilience factor that protects cancer cells from these stressors. In this review, we explore the dual role of MYC in both driving and mitigating cellular stress to achieve its oncogenic function. We also examine how MYC‐induced transcriptional and replicative stress generates potentially immunogenic nucleic acid species while simultaneously helping cancer cells evade host immune recognition. We propose a model in which MYC plays a critical role in managing the stress it induces, thereby maintaining a balance that promotes tumor growth. Based on this model, we discuss potential therapeutic strategies targeting MYC‐dependent stress responses, offering new avenues for cancer treatment and highlighting the complexity of MYC‐driven oncogenesis.
Open AccessMYC: The Guardian of Its Own Chaos
MYC proteins are potent oncoproteins that drive tumorigenesis in a wide range of cancers, making it critical to understand their oncogenic functions and underlying mechanisms. Although MYC overexpression induces transcriptional and replication‐associated stress, recent studies have paradoxically identified MYC as a key resilience factor that protects cancer cells from these stressors. In this review, we explore the dual role of MYC in both driving and mitigating cellular stress to achieve its oncogenic function. We also examine how MYC‐induced transcriptional and replicative stress generates potentially immunogenic nucleic acid species while simultaneously helping cancer cells evade host immune recognition. We propose a model in which MYC plays a critical role in managing the stress it induces, thereby maintaining a balance that promotes tumor growth. Based on this model, we discuss potential therapeutic strategies targeting MYC‐dependent stress responses, offering new avenues for cancer treatment and highlighting the complexity of MYC‐driven oncogenesis.
- Open Access
- 16 February 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-18
PAF1c links S-phase progression to immune evasion and MYC function in pancreatic carcinoma
In pancreatic ductal adenocarcinoma (PDAC), endogenous MYC is required for S-phase progression and escape from immune surveillance. Here we show that MYC in PDAC cells is needed for the recruitment of the PAF1c transcription elongation complex to RNA polymerase and that depletion of CTR9, a PAF1c subunit, enables long-term survival of PDAC-bearing mice. PAF1c is largely dispensable for normal proliferation and regulation of MYC target genes. Instead, PAF1c limits DNA damage associated with S-phase progression by being essential for the expression of long genes involved in replication and DNA repair. Surprisingly, the survival benefit conferred by CTR9 depletion is not due to DNA damage, but to T-cell activation and restoration of immune surveillance. This is because CTR9 depletion releases RNA polymerase and elongation factors from the body of long genes and promotes the transcription of short genes, including MHC class I genes. The data argue that functionally distinct gene sets compete for elongation factors and directly link MYC-driven S-phase progression to tumor immune evasion.
- 16 February 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-18
Open AccessPAF1c links S-phase progression to immune evasion and MYC function in pancreatic carcinoma
In pancreatic ductal adenocarcinoma (PDAC), endogenous MYC is required for S-phase progression and escape from immune surveillance. Here we show that MYC in PDAC cells is needed for the recruitment of the PAF1c transcription elongation complex to RNA polymerase and that depletion of CTR9, a PAF1c subunit, enables long-term survival of PDAC-bearing mice. PAF1c is largely dispensable for normal proliferation and regulation of MYC target genes. Instead, PAF1c limits DNA damage associated with S-phase progression by being essential for the expression of long genes involved in replication and DNA repair. Surprisingly, the survival benefit conferred by CTR9 depletion is not due to DNA damage, but to T-cell activation and restoration of immune surveillance. This is because CTR9 depletion releases RNA polymerase and elongation factors from the body of long genes and promotes the transcription of short genes, including MHC class I genes. The data argue that functionally distinct gene sets compete for elongation factors and directly link MYC-driven S-phase progression to tumor immune evasion.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S2 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
Histological analyses of transplanted tumors.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
Histological analyses of transplanted tumors.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S4 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
Characterization of MYC depletion.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
Characterization of MYC depletion.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S3 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
Characterization of MYC depletion.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
Characterization of MYC depletion.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S2 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
Histological analyses of transplanted tumors.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
Histological analyses of transplanted tumors.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S8 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
TBK1-dependent regulation of NF-kB-dependent gene expression.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
TBK1-dependent regulation of NF-kB-dependent gene expression.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S6 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
Further characterization of dsRNA species.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
Further characterization of dsRNA species.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S7 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
Role of MIZ1 in gene regulation.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
Role of MIZ1 in gene regulation.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S4 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
Characterization of MYC depletion.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
Characterization of MYC depletion.